Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

Vitamin C is an antioxidant and inhibitor of carcinogenic N-nitroso compound production in the stomach. Higher dietary vitamin C consumption is associated with decreased risk of gastric cancer (GC) in numerous case-control studies, but data from prospective studies are limited, particularly so for blood measures of vitamin C. The objective of this study was to determine the association of plasma and dietary vitamin C levels with the risk of GC in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC), a large cohort involving 10 European countries. Using a fluorometric method, vitamin C was measured in pre-diagnostic plasma from 215 GC cases (matched controls = 416). Conditional logistic regression models adjusted by body mass index, total energy intake, smoking status/duration/intensity and Helicobacter pylori infection status were used to estimate relative cancer risks. No association with GC risk was observed for dietary vitamin C, whereas an inverse GC risk was observed in the highest versus lowest quartile of plasma vitamin C [odds ratio (OR) = 0.55, 95% confidence interval (CI) = 0.31-0.97, P(trend) = 0.043], which was maintained after exclusion of cases with <or=2 years follow-up (OR = 0.40, 95% CI = 0.19-0.83, P(trend) = 0.064). The inverse association was more pronounced in subjects consuming higher levels of red and processed meats, a factor that may increase endogenous N-nitroso compound production. The effect of plasma vitamin C was not different by GC anatomical subsite (cardia/non-cardia) or histological subtype (diffuse/intestinal), and there was no significant interaction of effect with H.pylori. The results of this study show, in a prospective setting, an inverse association of GC risk with high levels of plasma vitamin C and suggest an interaction with the intake of red and processed meats, whose consumption may elevate endogenous N-nitroso compound production.

[1]  F. Clavel-Chapelon,et al.  Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC–EURGAST) , 2006, International journal of cancer.

[2]  E. Riboli,et al.  An approach to estimate between- and within-group correlation coefficients in multicenter studies: plasma carotenoids as biomarkers of intake of fruits and vegetables. , 2005, American journal of epidemiology.

[3]  D. Albanes,et al.  Fruits, Vegetables, and Antioxidants and Risk of Gastric Cancer among Male Smokers , 2005, Cancer Epidemiology Biomarkers & Prevention.

[4]  Elio Riboli,et al.  Long-term Cryoconservation and Stability of Vitamin C in Serum Samples of the European Prospective Investigation into Cancer and Nutrition , 2005, Cancer Epidemiology Biomarkers & Prevention.

[5]  M. Farthing,et al.  The roles of vitamin C in Helicobacter pylori associated gastric carcinogenesis. , 2005, Chinese journal of digestive diseases.

[6]  Jian-Min Yuan,et al.  Prediagnostic levels of serum micronutrients in relation to risk of gastric cancer in Shanghai, China. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  E. Samoli,et al.  Flavonoids, vitamin C and adenocarcinoma of the stomach , 2004, Cancer Causes & Control.

[8]  K. Chayama,et al.  Gastric juice nitrite and vitamin C in patients with gastric cancer and atrophic gastritis: is low acidity solely responsible for cancer risk? , 2003, European journal of gastroenterology & hepatology.

[9]  Elio Riboli,et al.  Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. , 2003, The American journal of clinical nutrition.

[10]  S. Khanzode,et al.  Serum and plasma concentration of oxidant and antioxidants in patients of Helicobacter pylori gastritis and its correlation with gastric cancer. , 2003, Cancer letters.

[11]  S. Tsugane,et al.  The effect of 5‐year vitamin C supplementation on serum pepsinogen level and Helicobacter pylori infection , 2003, Cancer science.

[12]  F. Clavel-Chapelon,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics , 2002, Public Health Nutrition.

[13]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[14]  S. Mayne,et al.  Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. , 2002, The Journal of nutrition.

[15]  S. Bingham,et al.  Effect of white versus red meat on endogenous N-nitrosation in the human colon and further evidence of a dose response. , 2002, The Journal of nutrition.

[16]  Y. Akyön.  Effect of antioxidants on the immune response of Helicobacter pylori. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  M. Farthing,et al.  Effect of physiological concentrations of vitamin C on gastric cancer cells and Helicobacter pylori , 2002, Gut.

[18]  M. Gammon,et al.  Nutrient intake and risk of subtypes of esophageal and gastric cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  B. Halliwell.  Vitamin C and genomic stability. , 2001, Mutation research.

[20]  M. Woodward,et al.  Helicobacter pylori infection reduces systemic availability of dietary vitamin C , 2001 .

[21]  M. Blaser,et al.  Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. , 2000, Journal of the National Cancer Institute.

[22]  A. Wolk,et al.  Antioxidants and cancers of the esophagus and gastric cardia , 2000, International journal of cancer.

[23]  L J Schouten,et al.  Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. , 2000, International journal of epidemiology.

[24]  A. Wolk,et al.  Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: A population‐based case‐control study in Sweden , 2000, International journal of cancer.

[25]  R. Goldbohm,et al.  Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma , 2000, Cancer.

[26]  G. Woollard,et al.  Gastric juice ascorbic acid is related to Helicobacter pylori infection but not ethnicity , 1999, Journal of gastroenterology and hepatology.

[27]  P. Ernst,et al.  Review article: the role of inflammation in the pathogenesis of gastric cancer , 1999, Alimentary pharmacology & therapeutics.

[28]  P. I. Reed,et al.  Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[29]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[30]  Z. W. Zhang,et al.  The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach , 1998, Gut.

[31]  Zuo-Feng Zhang,et al.  The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma , 1997, Cancer.

[32]  Elio Riboli,et al.  The EPIC Project: Rationale and study design , 1997 .

[33]  T. Key,et al.  Stability of vitamins A, C, and E, carotenoids, lipids, and testosterone in whole blood stored at 4 degrees C for 6 and 24 hours before separation of serum and plasma. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[34]  J. B. Park,et al.  Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Axon,et al.  Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. , 1996, Carcinogenesis.

[36]  T. J. Doyle,et al.  Retinol, antioxidant vitamins, and cancers of the upper digestive tract in a prospective cohort study of postmenopausal women. , 1995, American journal of epidemiology.

[37]  E Riboli,et al.  Calibration of dietary intake measurements in prospective cohort studies. , 1995, American journal of epidemiology.

[38]  A. Nissinen,et al.  Average intake of anti‐oxidant (PRO)vitamins and subsequent cancer mortality in the 16 cohorts of the seven countries study , 1995, International journal of cancer.

[39]  S. Mirvish,et al.  Experimental evidence for inhibition of N-nitroso compound formation as a factor in the negative correlation between vitamin C consumption and the incidence of certain cancers. , 1994, Cancer research.

[40]  P. Correa,et al.  Phenotypic and genotypic events in gastric carcinogenesis. , 1994, Cancer research.

[41]  K. McColl,et al.  Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. , 1994, Gut.

[42]  L. Hansson,et al.  Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. , 1993, Gastroenterology.

[43]  E. Wynder,et al.  Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia , 1993, Cancer Causes & Control.

[44]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[45]  H. Stähelin,et al.  Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective Basel Study. , 1991, American journal of epidemiology.

[46]  J. Vuilleumier,et al.  Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment , 1989 .

[47]  H. Bartsch,et al.  Inhibitors of endogenous nitrosation. Mechanisms and implications in human cancer prevention. , 1988, Mutation research.

[48]  P. Garry,et al.  Ascorbic acid intake and plasma levels in healthy elderly people. , 1987, The American journal of clinical nutrition.

[49]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[50]  Young-Sik Kim,et al.  Effect modification by vitamin C on the relation between gastric cancer and Helicobacter pylori , 2004, European Journal of Epidemiology.

[51]  N. Lunet,et al.  Does vitamin C dietary intake modify the association between Helicobacter pylori infection and gastric cancer? , 2004, European Journal of Epidemiology.

[52]  M. Gail,et al.  Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2000, Journal of the National Cancer Institute.

[53]  Zuo-Feng Zhang,et al.  Adenocarcinomas of the esophagus and gastric cardia: the role of diet. , 1997, Nutrition and cancer.

[54]  E Riboli,et al.  The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. , 1997, International journal of epidemiology.

[55]  H Boeing,et al.  The relative validity of vitamin intakes derived from a food frequency questionnaire compared to 24-hour recalls and biological measurements: results from the EPIC pilot study in Germany. European Prospective Investigation into Cancer and Nutrition. , 1997, International journal of epidemiology.

[56]  M. Ocké.  European prospective investigation into cancer and nutrition. Voedingsnavraag in de EPIC studie. , 1996 .

[57]  Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. , 1994, IARC monographs on the evaluation of carcinogenic risks to humans.

[58]  D. Forman,et al.  Risk factors for stomach cancer in sixty-five Chinese counties. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[59]  J. Primrose,et al.  Gastric juice ascorbic acid: effects of disease and implications for gastric carcinogenesis. , 1991, The American journal of clinical nutrition.